TAMOTEX BLISTER 20 - Euro-Pharmacies

Since tamoxifen citrate’s FDA approval in 1977, it has served as a critical anti-estrogen for treating and preventing breast cancer. Its selective blocking of estrogen in breast tissue has proven life-saving in hormone-sensitive cancers. Tamoxifen is also embraced by bodybuilders for its ability to block estrogenic side effects like gynecomastia without disturbing the positive liver effects of estrogen. Its impact on stimulating LH production helps support testosterone recovery after steroid cycles, which can be otherwise suppressed by anabolic use​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about TAMOTEX BLISTER 20 by Euro-Pharmacies, consult with your doctor or healthcare professional.